Weinand Dieter 4

What Happened
Dieter Weinand, a director of Replimune Group, reported an acquisition-type award on 2026-04-01 covering 44,500 shares. The Form 4 records this as a derivative grant (transaction code A) with a reported price of $0.00 — meaning Weinand received an award/option-like instrument rather than an open-market purchase or sale.

Key Details

• Transaction date: April 1, 2026 (reported on Form 4 filed April 7, 2026).
• Transaction type/code: A (Grant/award/acquisition), derivative instrument.
• Amount: 44,500 shares; reported price: $0.00.
• Vesting: Footnote states the shares underlying this option vest entirely on April 1, 2027.
• Shares owned after transaction: Not specified in the filing.
• Timeliness: Form 4 was filed late; the filing notes the delay was due to an inadvertent administrative error (timeliness flag: L).

Context
This was a compensation-style award of a derivative instrument (option/RSU-like) that vests in one year — not an immediate cash purchase or sale. Such awards are common for directors and do not by themselves indicate the director is buying or selling stock for market-view reasons. Because the filing was late, real-time transparency was reduced, though the late filing note says the delay was inadvertent.